Carenostics has filed a notice of an exempt offering of securities to raise $4,743,245.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Carenostics is raising $4,743,245.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Bharat Rao played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Carenostics
Carenostics develops healthcare AI solutions to identify opportunities for earlier clinical intervention with chronic disease patients. We learn machine learning models from patient data collected in routine care, and integrate directly into provider EHRs to help physicians identify patients with undiagnosed chronic disease, project their decline over time, and match them to guideline / evidence-based treatment. Carenostics partners with leading providers, payers, pharma companies, care management companies, academics, and government agencies to address the gaps in chronic disease care. Our flagship solution, CKDx, is a clinical decision support tool developed with the goal of eradicating undiagnosed chronic kidney disease while reducing the disparities in care faced by minority populations.
To learn more about Carenostics, visit http://www.carenostics.com/
Contact:
Bharat Rao, Chief Executive Officer
484-753-2942
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.